Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment

  • Jonathan I. Silverberg (George Washington University) (Creator)
  • A. Wollenberg (Creator)
  • Linda Stein Gold (Creator)
  • James Del Rosso (Contributor)
  • Gil Yosipovitch (Creator)
  • Peter A Lio (Creator)
  • Jose-Manuel Carrascosa (Creator)
  • G. Gallo (Creator)
  • Yuxin Ding (Creator)
  • Zhenhui Xu (Creator)
  • Marta Casillas (Creator)
  • Evangeline J. Pierce (Creator)
  • Helena Agell (Creator)
  • Sonja Ständer (Creator)

Dataset

Description

The above visual graphs represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).
Date made available2024
PublisherAdis Journals

Cite this